What is Stem Cell Therapy?
Stem Cell Therapy is the use of living cells to restore or improve the function of an organ and tissues whose have been injured.
Mexico Stem Cell Therapy is a medical tourism facilitator helping patients find inexpensive stem cell treatments for various ailments.
Mexico Stem Cell Therapy, is a service of Mexico Bariatric Center, a medical tourism facilitator. MexicoStemCellTherapy.com is a resource, educating patients the various stem cell therapies in Mexico.
As more stem cell therapy studies show positive improvement in the lives of patients, people need a better resource on the ever-changing world of stem cell therapy. Thus, Mexico Stem Cell Therapy was born.
Stem Cell Therapies in Mexico
Undergoing various stem cell treatments in Mexico is considerably less expensive than undergoing them in the U.S. or Canada. Mexico has been practicing the art of stem cell therapies for years with successful results.
We’ve partnered with DNA Vita Therapeutics, a certified medical provider, a company that has been in business since 2005 and has grown to 10 clinics in Mexico.
If you’re looking for more information please contact our team.
Stem Cell News
- New platform poised to be next generation of genetic medicines
- Gene controls bone-to-fat ratio in bone marrow
- Engineered cancer cells can fight primary and metastatic cancer
- Kidney podocytes, all grown up
- Researchers confine mature cells to turn them into stem cells
- Finding a weak link in the frightful parasite Schistosoma
- New method for turning skin cells into pluripotent stem cells
- Muscle stem cells derived from teratomas
- SATB1 vital for maintenance of hematopoietic stem cells
- Stem cell therapy drug may protect against smoke-related COPD symptoms
- Stem cells restore function in primate heart-failure study
- Alzheimer's in mini format: A novel tool to study disease mechanisms and possible remedies
- Direct conversion of non-neuronal cells into nerve cells
- The novel function of self-renewal factor of spermatogonial stem cells is identified
- CAR-T immunotherapies may have a new player